Patent safety alert: Risk of severe harm and death due to withdrawing insulin from pen devices

Document first published:
Page updated:
Topic:
Publication type:

This alert has been issued to warn NHS providers of the risk of severe harm and death if an insulin needle and syringe is used to administer insulin withdrawn directly from a pen device or replacement cartridge.

Document

Patent safety alert: Risk of severe harm and death due to withdrawing insulin from pen devices

Patent safety alert: Risk of severe harm and death due to withdrawing insulin from pen devices

  • PDF
  • 179 KB
  • 2 pages

Media

Summary

This short video explains that an insulin syringe and needle must not be used to withdraw medication directly from a patient’s insulin pen device. Organisations are asked to ensure staff have access to appropriate equipment and training for administering insulin using these devices.